Evidence map›Paper›PMID 23945723›Full record

Trial reportThe American journal of clinical nutrition2013

Arginine appearance and nitric oxide synthesis in critically ill infants can be increased with a protein-energy-enriched enteral formula.

Carlijn T I de Betue, Koen F M Joosten, Nicolaas E P Deutz, Anita C E Vreugdenhil, Dick A van Waardenburg

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Quantifications of Lipid KineticsJournal of lipid and atherosclerosis · 2020
    Review
  13. The intestinal-renal axis for arginine synthesis is present and functional in the neonatal pig.American journal of physiology. Endocrinology and metabolism · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Carlijn T I de BetueDepartment of Pediatrics, Maastricht University Medical Center, Maastricht, Netherlands.
Koen F M Joosten
Nicolaas E P Deutz
Anita C E Vreugdenhil
Dick A van Waardenburg
Nederlandse Vereniging voor Kindergeneeskunde · NLMaastricht University · NL

Funding

Optimal Amino Acid Nutrition in SepsisR01GM084447 · NIGMS · TEXAS A&M UNIVERSITY · PI DEUTZ, NICOLAAS E, WOLFE, ROBERT R · 2009 to 2012
$1.5M
TSQ Vantage Bundle with Acquity UltraPerformance LCS10RR027047 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI DEUTZ, NICOLAAS E · 2010 to 2010
$398k
NCRR NIH HHS S10RR027047NIGMS NIH HHS R01GM084447
6 · The paper itself

Abstract

backgroundArginine is considered an essential amino acid during critical illness in children, and supplementation of arginine has been proposed to improve arginine availability to facilitate nitric oxide (NO) synthesis. Protein-energy-enriched enteral formulas (PE-formulas) can improve nutrient intake and promote anabolism in critically ill infants. However, the effect of increased protein and energy intake on arginine metabolism is not known.

objectiveWe investigated the effect of a PE-formula compared with that of a standard infant formula (S-formula) on arginine kinetics in critically ill infants.

designA 2-h stable-isotope tracer protocol was conducted in 2 groups of critically ill infants with respiratory failure because of viral bronchiolitis, who received either a PE-formula (n = 8) or S-formula (n = 10) in a randomized, blinded, controlled setting. Data were reported as means ± SDs.

resultsThe intake of a PE-formula in critically ill infants (aged 0.23 ± 0.14 y) resulted in an increased arginine appearance (PE-formula: 248 ± 114 μmol · kg(-1) · h(-1); S-formula: 130 ± 53 μmol · kg(-1) · h(-1); P = 0.012) and NO synthesis (PE-formula: 1.92 ± 0.99 μmol · kg(-1) · h(-1); S-formula: 0.84 ± 0.36 μmol · kg(-1) · h(-1); P = 0.003), whereas citrulline production and plasma arginine concentrations were unaffected.

conclusionIn critically ill infants with respiratory failure because of viral bronchiolitis, the intake of a PE-formula increases arginine availability by increasing arginine appearance, which leads to increased NO synthesis, independent of plasma arginine concentrations. This trial was registered at www.trialregister.nl as NTR515.

Indexed as

Infant FormulaArginineCitrullineCritical IllnessDietary ProteinsDietary SupplementsEnergy IntakeEnteral NutritionFemaleFood, FortifiedHumansInfantIntensive Care Units, PediatricKineticsMaleNitric OxideArginineCitrullineDietary ProteinsNitric Oxide

Identifiers

PMID23945723
PMCPMC3778863
OpenAlexW2110006425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.